(Q37621548)

21 August 2017

title

Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates (English)

1 reference

21 August 2017

0 references

1 reference

David S Hoff

1

1 reference

21 August 2017

Roger A Wilcox

2

1 reference

21 August 2017

Lisa M Tollefson

3

1 reference

21 August 2017

Polina G Lipnik

4

1 reference

21 August 2017

Amy R Commers

5

1 reference

21 August 2017

Meixia Liu

6

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

29

1 reference

21 August 2017

issue

11

1 reference

21 August 2017

page(s)

1297-1305

1 reference

Clinical pharmacokinetics of antibacterial drugs in neonates

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

"Random" gentamicin concentrations do not predict trough levels in neonates receiving once daily fixed dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Population pharmacokinetics of gentamicin in premature newborns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

A simple, weight-based, extended-interval gentamicin dosage protocol for neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Gentamicin and tobramycin in neonates: comparison of a new extended dosing interval regimen with a traditional multiple daily dosing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

The kinetic profile of gentamicin in premature neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Use of higher dose extended interval aminoglycosides in a neonatal intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Gentamicin interval in newborn infants as determined by renal function and postconceptional age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Pharmacokinetics and antibacterial activity of daily gentamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Chronic liver disease associated with childhood ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Aminoglycoside toxicity in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Time course of trough serum gentamicin concentrations in preterm and term neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Effect of aminoglycoside therapy on renal function in full-term infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Renal function and effect of aminoglycoside therapy during the first ten days of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Acute effects of gentamicin on urinary electrolyte excretion in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Comparison of two gentamicin dosing schedules in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Extended interval dosing of gentamicin in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Once-daily gentamicin dosing in newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Incidence of potentially toxic concentrations of gentamicin in the neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Once-daily gentamicin dosing for the preterm and term newborn: proposal for a simple regimen that achieves target levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Population pharmacokinetics of gentamicin in preterm neonates: evaluation of a once-daily dosage regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

Pharmacokinetics of gentamicin in very low birth weight preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

A multicenter evaluation of gentamicin therapy in the neonatal intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

The effect of postnatal age on gentamicin pharmacokinetics in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1297

21 January 2018

Identifiers

DOI

10.1592/PHCO.29.11.1297

1 reference

21 August 2017

1 reference